Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 12/20 | 0.61 |
| ▸ | FNTB | P49356 | 12/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 2/20 | 0.40 |
| ▸ | HTR7 | P34969 | 2/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL651936 | 1.00 | FNTA (0.61) | FNTAFNTBTHRBABCC9HTR1A | |
| SCHEMBL650167 | 0.95 | FNTA (0.67) | FNTAFNTBTHRB | |
| SCHEMBL651191 | 0.95 | FNTA (0.67) | FNTAFNTBTHRB | |
| SCHEMBL650165 | 0.95 | FNTA (0.67) | FNTAFNTBTHRB | |
| SCHEMBL649201 | 0.94 | FNTA (0.60) | FNTAFNTBTHRBHDAC8F10 | |
| SCHEMBL649200 | 0.94 | FNTA (0.60) | FNTAFNTBTHRBHDAC8F10 | |
| SCHEMBL650207 | 0.89 | FNTA (0.61) | FNTAFNTBTHRBHTR1AHTR7 | |
| SCHEMBL648851 | 0.89 | FNTA (0.71) | FNTAFNTBTHRB | |
| SCHEMBL653554 | 0.89 | FNTA (0.71) | FNTAFNTBTHRB | |
| SCHEMBL648852 | 0.89 | FNTA (0.71) | FNTAFNTBTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11794161-B1 | Reduced permeability microcapsules | TRUCAPSOL, LLC (US) | 2023-10-24 | — | — | US | claimed |
| US-11007501-B2 | Reduced permeability microcapsules | TRUCAPSOL LLC (US) | 2021-05-18 | — | — | US | claimed |
| US-20190275490-A1 | REDUCED PERMEABILITY MICROCAPSULES | ALTER DOMUS (US) LLC | 2019-09-12 | — | — | US | claimed |
| WO-2019173062-A1 | REDUCED PERMEABILITY MICROCAPSULES | TRUCAPSOL, LLC (US) | 2019-09-12 | — | — | WO | claimed |
| US-7884113-B2 | Tetrahydroquinoline derivatives as cannabinoid receptor modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-02-08 | — | — | US | claimed |
| US-20080194625-A1 | TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS | BRISTOL-MYERS SQUIBB COMPANY | 2008-08-14 | — | — | US | claimed |
| US-20050014786-A1 | Tetrahydroquinoline derivatives as cannabinoid receptor modulators | BRISTOL-MYERS SQUIBB COMPANY | 2005-01-20 | — | — | US | claimed |
| US-11931711-B2 | Microcapsule clusters | ENCAPSYS, LLC (US) | 2024-03-19 | — | — | US | disclosed |
| US-11889831-B2 | Aqueous microcapsule slurry | ENCAPSYS, LLC (US) | 2024-02-06 | — | — | US | disclosed |
| US-11794161-B1 | Reduced permeability microcapsules | TRUCAPSOL, LLC (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230264161-A1 | Microcapsule Clusters | ENCAPSYS LLC (US) | 2023-08-24 | — | — | US | disclosed |
| EP-3390483-B1 | ENCAPSULATION | PROCTER & GAMBLE (US) | 2022-05-18 | — | — | EP | disclosed |
| US-11260359-B2 | Incorporation of chitosan in microcapsule wall | ENCAPSYS, LLC | 2022-03-01 | — | — | US | disclosed |
| US-20090274905-A1 | Cationic microcapsule particles | APPLETON PAPERS INC. (US) | 2009-11-05 | — | — | US | disclosed |
| US-20080194625-A1 | TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS | BRISTOL-MYERS SQUIBB COMPANY | 2008-08-14 | — | — | US | disclosed |
| US-20050014786-A1 | Tetrahydroquinoline derivatives as cannabinoid receptor modulators | BRISTOL-MYERS SQUIBB COMPANY | 2005-01-20 | — | — | US | disclosed |
| US-RE37597-E1 | Golf ball covers | ACUSHNET COMPANY | 2002-03-19 | — | — | US | disclosed |
| US-5971869-A | CORE COMPRISING POLYBUTADIENE AND A TERPOLYMER OF AN OLEFINIC HYDROCARBON, AN UNSATURATED ACRYLATE AND A MONOMER FROM THE GROUP OF CARBON MONOXIDE, UNSATURATED ANHYDRIDES OR AN UNSATURATED ESTER HAVING AN EPOXIDE GROUP; DURABILITY; FEEL | ACUSHNET COMPANY (US) | 1999-10-26 | — | — | US | disclosed |
| WO-1998051741-A1 | GOLF BALL COMPOSITION | ACUSHNET COMPANY (US) | 1998-11-19 | — | — | WO | disclosed |
| US-5631324-A | BLEND OF IONOMER AND TERPOLYMER | ACUSHNET COMPANY (US) | 1997-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190275490-A1 | REDUCED PERMEABILITY MICROCAPSULES | ABCC1, CHMP4B, SLC18A1 | FNTA 3700/4885FNTB 2747/4885THRB 2540/4885 |
| US-11007501-B2 | Reduced permeability microcapsules | ABCC1, CHMP4B, SLC18A1 | FNTA 3700/4885FNTB 2747/4885THRB 2540/4885 |
| US-20050014786-A1 | Tetrahydroquinoline derivatives as cannabinoid receptor modulators | CNR2, CNR1, OPRL1 | FNTA 1368/4885FNTB 2071/4885THRB 809/4885 |
| US-11794161-B1 | Reduced permeability microcapsules | CHMP4B, NSF, ACR | FNTA 3820/4885FNTB 3563/4885THRB 3545/4885 |
| US-20080194625-A1 | TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS | CNR2, CNR1, OPRL1 | FNTA 1368/4885FNTB 2071/4885THRB 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.